Premium
Survival after radical cystectomy of non‐bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing‐risks analysis
Author(s) -
Abdollah Firas,
Sun Maxine,
Jeldres Claudio,
Schmitges Jan,
Thuret Rodolphe,
Djahangirian Orchidee,
Tian Zhe,
Shariat Shahrokh F.,
Perrotte Paul,
Montorsi Francesco,
Karakiewicz Pierre I.
Publication year - 2012
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2011.10357.x
Subject(s) - cystectomy , medicine , bladder cancer , stage (stratigraphy) , oncology , cancer , carcinoma , epidemiology , carcinoma in situ , pathological , urology , proportional hazards model , urothelial carcinoma , biology , paleontology
Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? To date, there is controversy about the impact of histological subtype of bladder cancer (nonbilharzial squanous cell carcinoma vs. urothelial carcinoma) on cancer control outcomes. Our study shows that the histological subtype may have an impact on the stage of bladder cancer at presentation. However, after adjusting to stage, the histological subtype has no impact on cancer control outcomes. OBJECTIVES• To test the effect of histological subtype (NBSCC vs UC) on cancer‐specific mortality (CSM), after adjusting for other‐cause mortality (OCM). • In Western countries, non‐bilharzial squamous cell carcinoma (NBSCC) is the second most common histological subtype in bladder cancer (BCa) after urothelial carcinoma (UC).PATIENTS AND METHODS• We identified 12 311 patients who were treated with radical cystectomy (RC) between 1988 and 2006, within 17 Surveillance, Epidemiology and End Results (SEER) registries. • Univariable and multivariable competing‐risks analyses tested the relationship between histological subtype and CSM, after accounting for OCM. • Covariates consisted of age, sex, year of surgery, race, pathological T and N stages, as well as tumour grade.RESULTS• Histological subtype was NBSCC in 614 (5%) patients vs UC in 11 697 (95%) patients. • At RC, the rate of non‐organ confined (NOC) BCa was higher in NBSCC patients than in their UC counterparts (71.7% vs 52.2%; P < 0.001). • After adjustment for OCM, The 5‐year cumulative CSM rates were 25.0% vs 19.8% ( P = 0.2) for patients with NBSCC vs UC organ confined (OC) BCa, respectively. The same rates were 46.3% vs 49.3% in patients with NOC BCa ( P = 0.1). • In multivariable competing‐risks analyses, histological subtype (NBSCC vs UC) failed to achieve independent predictor status of CSM in patients with OC (hazard ratio, 1.2; P = 0.06) or NOC BCa (hazard ratio, 1.1; P = 0.1).CONCLUSIONS• At RC, the rate of NOC BCa is higher in NBSCC patients than in their UC counterparts. • Despite a more advanced stage at surgery, NBSCC histological subtype is not associated with a less favourable CSM than UC histological subtype, after accounting for OCM and the extent of the disease (OC vs NOC).